Registration Options

Activity Dates: 04/25/2022 - 04/25/2025

Session Time and Location

The live session is complete.

Target Audience

If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.

Session Summary

Pharmacists learn from various colleagues throughout their training and employment. Time and competing priorities prevent vetting all discussions with a thorough drug information search. Information changes over time. As such, some practices and concerns relevant to neuropsychiatry practice today may be inaccurate or based on an incomplete understanding of the evidence. It is important to periodically re-evaluate our practices to avoid perpetuation of misconceptions. In this session, participants will evaluate evidence-based medicine to clarify whether common ideas heard and shared in practice today are fact, myth or whether the verdict is still out.

Course Requirements

To receive ACPE credit for this session, you must:

  • Sign in (or create a FREE account).
  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the post-test at the end of the activity no later than the closing activity date.
  • Complete the evaluation at the end of the activity.
  • If necessary, complete the post-test retest no later than the closing activity date.
  • Receive a passing grade (70%).
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Upon successful completion, ACPE credit is reported within 24 hours to CPE Monitor although transcripts can be retrieved by participants online in their ACPE Transcript.

Faculty Information and Disclosures

Learning Objectives

  1. Recall evidence to determine if mirtazapine and quetiapine have a dose-related or inverse dose-related response with regard to sedation.
  2. Review the evidence for efficacy of typical and atypical antipsychotics for the treatment of negative symptoms associated with schizophrenia.
  3. Discuss the risks of concomitant use of antidepressants with linezolid or triptans.
  4. Explain evidence for re-titration of lamotrigine and compare to package labeling.

Continuing Education Credit and Disclosures

Activity Dates: 04/25/2022 - 04/25/2025
ACPE Contact Hours: 1
ACPE Number: 0284-0000-22-036-H01-P (Knowledge)
Nursing Credit Reminder: Note that ACPE credit is accepted for certification renewal.

ACPEThe College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.